Surrozen, Inc./DE — Director's Dealing 2025

Mar 26, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Surrozen, Inc./DE (SRZN)
CIK: 0001824893
Period of Report: 2025-03-24

Reporting Person: Parker Craig C (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-24	Series A Common Stock Warrant (right to buy)	$16.96	D	1474	Disposed	2029-04-04	Common Stock (1474)	Direct
2025-03-24	Series B Common Stock Warrant (right to buy)	$15.71	D	1603	Disposed		Common Stock (1603)	Direct
2025-03-24	Series C Common Stock Warrant (right to buy)	$16	D	5712	Disposed		Common Stock (5712)	Direct
2025-03-24	Series D Common Stock Warrant (right to buy)	$16	D	5712	Disposed		Common Stock (5712)	Direct
2025-03-24	Series A Common Stock Warrant (right to buy)	$12.45	A	1474	Acquired	2029-04-04	Common Stock (1474)	Direct
2025-03-24	Series B Common Stock Warrant (right to buy)	$12.45	A	1603	Acquired		Common Stock (1603)	Direct

Footnotes

F1: The warrant was repriced pursuant to a Warrant Cancellation and Amendment Agreement effective March 24, 2025 to decrease the per share exercise price of the warrant from $16.96 to $12.45.

F2: The warrant was repriced pursuant to a Warrant Cancellation and Amendment Agreement effective March 24, 2025 to decrease the per share exercise price of the warrant from $15.71 to $12.45.

F3: The warrant expires on the fifth trading day following the occurrence of the Series B Milestone Event (as defined in the Series B Common Stock Warrant). In the event the Series B Milestone Event has not occurred prior to the fifth anniversary of the issuance date of the warrant, the warrant will automatically terminate on such anniversary date.

F4: The warrant was cancelled pursuant to a Warrant Cancellation and Amendment Agreement effective March 24, 2025.

F5: The warrant is exercisable for 30 days after the earlier of (i) the occurrence of the Series C Milestone Event (as defined in the Series C Common Stock Warrant) and (ii) a Fundamental Transaction (as defined in the Series C Common Stock Warrant).

F6: The warrant is exercisable for 30 days after the earlier of (i) the occurrence of the Series D Milestone Event (as defined in the Series D Common Stock Warrant) and (ii) a Fundamental Transaction (as defined in the Series D Common Stock Warrant).